Mesoporous silica nanoparticles (MSNs) bearing poly(l-histidine)-grafted nanogates were prepared by surface-initiated ROP. The obtained polypeptide-functionalized MSNs were used as smart pH-responsive nanocarriers for controlled drug release applications.

The aim of this work was to evaluate the effectiveness of neat chitosan (CS) and its derivatives with 2-acrylamido-2-methyl-1-propanesulfonic acid (AAMPS) and [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide (MEDSP) as appropriate nanocarriers for the simultaneous ocular administration of dexamethasone sodium phosphate (DxP) and chloramphenicol (CHL). The derivatives CS-AAMPS and CS-MEDSP have been synthesized by free-radical polymerization and their structure has been proved by Fourier-Transformed Infrared Spectroscopy (FT-IR) spectroscopy. Both derivatives exhibited low cytotoxicity, enhanced mucoadhesive properties and antimicrobial activity against Staphylococcus aureus (S.aureus) and Escherichia coli (E. coli). Encapsulation was performed via ionic crosslinking gelation using sodium tripolyphosphate (TPP) as the crosslinking agent. Dynamic light scattering measurements (DLS) showed that the prepared nanoparticles had bimodal distribution and sizes ranging from 50–200 nm and 300–800 nm. Drugs were encapsulated in their crystalline (CHL) or amorphous (DexSP) form inside nanoparticles and their release rate was dependent on the used polymer. The CHL dissolution rate was substantially enhanced compared to the neat drug and the release time was extended up to 7 days. The release rate of DexSP was much faster than that of CHL and was prolonged up to 3 days. Drug release modeling unveiled that diffusion is the main release mechanism for both drugs. Both prepared derivatives and their drug-loaded nanoparticles could be used for extended and simultaneous ocular release formulations of DexSP and CHL drugs.

We present the synthesis of the novel monomer N^im-trityl-protected N-carboxy anhydride of L-histidine (Trt-HIS-NCA) for the synthesis of poly(L-histidine) (PHIS). Kinetic studies of the ring opening polymerization of Trt-HIS-NCA followed first order kinetics, indicating that the polymerization is “living”. The high purity of the synthesized monomer along with the use of high vacuum techniques resulted in the controlled polymerization of histidine in a variety of macromolecular architectures exhibiting high degrees of molecular and compositional homogeneity. The conformation of poly(L-histidine) (PHIS) was studied at different pH values and temperatures by circular dichroism, revealing that it adopts a random coil conformation at low pH and temperatures, a β-sheet conformation at higher pH, and probably a broken β-sheet conformation at higher temperatures. We found that the pK_a of the PHIS homopolymer depends on the molecular weight. Addition of hydrophobic amino acids randomly distributed along the PHIS chain hinders the organization of PHIS, resulting in the formation of the random coil conformation even at higher pH. The influence of either leucine (LEU) or γ-benzyl-L-glutamate (BLG) randomly distributed along the PHIS chain on the pK_a and degree of protonation in the terpolymers revealed that although the pK_a is lower, the protonation of PHIS increases at lower pH values, while it is lower at a higher pH as compared to that obtained for PHIS. The aggregates of PEO-b-P(HIS-co-PLEU(BLG)) in water were found to swell more by decreasing the pH and increasing the hydrophobic amino acids, and eventually become disrupted. Surprisingly, at pH = 7.4, the increase in temperature leads to lower aggregation of the PEO-b-PHIS due to the transition of the secondary structure. The results indicate that it is possible to fine-tune the protonation of PHIS as a function of pH and temperature, and thus to control the conditions where the aggregates will be disrupted, a prerequisite for drug and gene delivery applications.